Pharmacokinetic Equipment Supplied In Israel
2 equipment items found
Manufactured by:BiomX based inNess Ziona, ISRAEL
Phase 1b/2a clinical study in CF patients is composed of two parts. Results from Part 1 aimed to evaluate the safety, pharmacokinetics, and microbiologic/clinical activity are expected in Q3 of 2022. Results from Part 2 aimed to demonstrate safety and efficacy are expected by Q1 of 2023. ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
Although different organs are affected in IBD and PSC (gut in IBD and liver in PSC) the two diseases are thought to be related since approximately 70% of PSC patients also suffer from IBD. Results from a pharmacokinetic and safety Phase 1a study demonstrated safety and tolerability with successful delivery of a high concentration of viable phage to the lower gastrointestinal ...